PPARγ expression after a high-fat meal is associated with plasma superoxide dismutase activity in morbidly obese persons

Obesity

Volumn 18, Issue 5, 2010, Pages 952-958

  Garcia Fuentes, Eduardo ^a,b   Murri, Mora ^b   Garrido Sanchez, Lourdes ^a   Garcia Serrano, Sara ^c   García Almeida, Jose M ^a   Moreno Santos, Inmaculada ^b   Tinahones, Francisco J ^a   MacIas Gonzalez, Manuel ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b Hospital University Carlos Haya de Málaga   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ARTICLE; BLOOD; FAT INTAKE; FEMALE; GENETICS; HUMAN; INSULIN RESISTANCE; LIPID PEROXIDATION; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; MORBID OBESITY; OXIDATIVE STRESS; PHYSIOLOGY; REGRESSION ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

DIETARY FATS; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEUKOCYTES, MONONUCLEAR; LIPID PEROXIDATION; MALE; MIDDLE AGED; OBESITY, MORBID; OXIDATIVE STRESS; PPAR GAMMA; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TRIGLYCERIDES;

EID: 77951665882     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.314     Document Type: Article

References (37)

1. Pieper GM, Meier DA, Hager SR. Endothelial dysfunction in a model of hyperglycemia and hyperinsulinemia. Am J Physiol 1995;269:H845-H850.
2. Turner RC, Millns H, Neil HA et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998;316:823-828.
3. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994;106:83-97.
4. Cardona F, Tinahones FJ. Relación de la hipertrigliceridemia postprandial con la resistencia a la insulina en pacientes con síndrome metabólico. Endocrinol Nutr 2006;53:345-352.
5. Prónai L, Hiramatsu K, Saigusa Y, Nakazawa H. Low superoxide scavenging activity associated with enhanced superoxide generation by monocytes from male hypertriglyceridemia with and without diabetes. Atherosclerosis 1991;90:39-47.
6. Tinahones FJ, Murri-Pierri M, Garrido-Sánchez L et al. Oxidative stress in severely obese persons is greater in those with insulin resistance. Obesity (Silver Spring) 2009;17:240-246.
7. Efe H, Deger O, Kirci D et al. Decreased neutrophil antioxidative enzyme activities and increased lipid peroxidation in hyperlipoproteinemic human subjects. Clin Chim Acta 1999;279:155-165.
8. Tushuizen ME, Nieuwland R, Scheffer PG et al. Two consecutive high-fat meals affect endothelial-dependent vasodilation, oxidative stress and cellular microparticles in healthy men. J Thromb Haemost 2006;4:1003-1010.
9. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond) 2006;30:400-418.
10. Picard F, Auwerx J. PPAR(gamma) and glucose homeostasis. Annu Rev Nutr 2002;22:167-197.
11. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998;391:79-82.
12. Macias-Gonzalez M, Cardona F, Queipo-Ortuño M et al. PPARgamma mRNA expression is reduced in peripheral blood mononuclear cells after fat overload in patients with metabolic syndrome. J Nutr 2008;138:903-907.
13. Fridlyand LE, Philipson LH. Oxidative reactive species in cell injury: mechanisms in diabetes mellitus and therapeutic approaches. Ann N Y Acad Sci 2005;1066:136-151.
14. Bertelsen M, Anggård EE, Carrier MJ. Oxidative stress impairs insulin internalization in endothelial cells in vitro. Diabetologia 2001;44:605-613.
15. Hwang J, Kleinhenz DJ, Lassègue B et al. Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol, Cell Physiol 2005;288:C899-C905.
16. Inoue I, Goto S, Matsunaga T et al. The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism 2001;50:3-11.
17. Soriguer F, García-Serrano S, García-Almeida JM et al. Changes in the serum composition of free-fatty acids during an intravenous glucose tolerance test. Obesity (Silver Spring) 2009;17:10-15.
18. Kintscher U, Law RE. PPARgamma-mediated insulin sensitization: the importance of fat versus muscle. Am J Physiol Endocrinol Metab 2005;288:E287-E291.
19. Hwang J, Kleinhenz DJ, Rupnow HL et al. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice. Vascul Pharmacol 2007;46:456-462.
20. Yoo HY, Chang MS, Rho HM. Induction of the rat Cu/Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid. Gene 1999;234:87-91.
21. Rojo-Martínez G, Esteva I, de Adana SR et al. Patterns of insulin resistance in the general population of southeast Spain. Diabetes Res Clin Pract 2004;65:247-256.
22. Matthews DR, Hosker J P, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
23. Lehmann JM, Moore LB, Smith-Oliver TA et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator- activated receptor gamma (PPAR gamma). J Biol Chem 1995;270:12953-12956.
24. Macias-Gonzalez M, Garcia-Fuentes E, Martin M, Tinahones FJ. Expression of peroxisome proliferator-activated receptor γ1 and γ2 in human adipose tissue is downregulated in obesity and related to insulin resistance. Diabetes 2008;57(Suppl 1):A759-A759.
25. Després J P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881-887.
26. Semple RK, Chatterjee VK, O'Rahilly S. PPAR gamma and human metabolic disease. J Clin Invest 2006;116:581-589.
27. Lionetti L, Mollica M P, Lombardi A et al. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation. Nutr Metab Cardiovasc Dis 2009;19:146-152.
28. Bindokas V P, Kuznetsov A, Sreenan S et al. Visualizing superoxide production in normal and diabetic rat islets of Langerhans. J Biol Chem 2003;278:9796-9801.
29. Talior I, Yarkoni M, Bashan N, Eldar-Finkelman H. Increased glucose uptake promotes oxidative stress and PKC-delta activation in adipocytes of obese, insulin-resistant mice. Am J Physiol Endocrinol Metab 2003;285: E295-E302.
30. Korthuis RJ, Kubes P, Tso P, Perry M, Granger DN. Transport kinetics for superoxide dismutase and catalase between plasma and interstitial fluid in the rat small intestine. Free Radic Biol Med 1991;11:293-298.
31. LaLonde C, Nayak U, Hennigan J, Demling R. Plasma catalase and glutathione levels are decreased in response to inhalation injury. J Burn Care Rehabil 1997;18:515-519.
32. Bagi Z, Koller A, Kaley G. PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with type 2 diabetes. Am J Physiol Heart Circ Physiol 2004;286:H742-H748.
33. Karlsson K, Marklund SL. Extracellular superoxide dismutase in the vascular system of mammals. Biochem J 1988;255:223-228.
34. Olusi SO. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord 2002;26:1159-1164.
35. Vincent HK, Innes KE, Vincent KR. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes Metab 2007;9:813-839.
36. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-412.
37. Garrido-Sánchez L, García-Almeida JM, García-Serrano S et al. Improved carbohydrate metabolism after bariatric surgery raises antioxidized LDL antibody levels in morbidly obese patients. Diabetes Care 2008;31: 2258-2264.